Awakn Life Sciences (TSE:AWKN) has released an update.
Awakn Life Sciences Corp., a company focused on developing treatments for substance use and mental health disorders, has upsized its private placement financing from $1,000,000 to $2,000,000 and announced the closing of a fourth tranche, securing an additional $394,286. The funds raised will support the company’s general working capital needs.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
